VTEX director exercises options, sells 199K shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
VTEX director Francisco Alvarez-Demalde reported the exercise of 182,000 stock options held for the benefit of Riverwood Capital GP II Ltd. and/or certain affiliates on November 9, 2026, at a $3.55 exercise price, acquiring 182,000 Class A common shares. The Riverwood-benefit holdings included sales of 182,000 and 16,640 Class A shares at a weighted average $3.90 per share; sale prices ranged from $3.90 to $3.925. The fully vested options had been extended until November 13, 2026, and sale proceeds are to be transferred as directed by Riverwood.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| In-the-Money Exercise | Stock Options F3, F1 | 182,000 | $0.00 | $0.00 |
| In-the-Money Exercise | Class A Common Shares F1 | 182,000 | $3.55 | $646K |
| Sale | Class A Common Shares F2, F1 | 182,000 | $3.90 | $710K |
| Sale | Class A Common Shares F2, F1 | 16,640 | $3.90 | $65K |
Footnotes (3)
- F1. These securities are held by Mr. Alvarez-Demalde for the benefit of Riverwood Capital GP II Ltd. and/or certain of its affiliates (collectively, "Riverwood"). Mr. Alvarez-Demalde is obligated to transfer the underlying shares upon settlement or any proceeds from the sale thereof as directed by Riverwood. Mr. Alvarez-Demalde disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities by Mr. Alvarez-Demalde for purposes of Section 16 or any other purposes.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from USD $3.90 to USD $3.925, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- F3. These stock options are fully vested. Exercise of these stock options were extended until November 13, 2026.
Key Figures
Key Terms
fully vested financial
weighted average price financial
in-the-money or at-the-money derivative security financial
beneficial ownership regulatory
foreign private issuer regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many VTEX options were exercised, and at what price?
AI-generated analysis. How Rhea-AI works. Not financial advice.